Evidence map›Paper›PMID 21727916›Full record

ArticleNature reviews. Cardiology2011

Coronary artery disease: how should the STICH trial results affect clinical practice?

Michael J Mack

Abstract read
PubMed Publisher
In one paragraph

Article in Nature reviews. Cardiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Organ-saving surgical alternatives to treatment of heart failure.Cardiovascular diagnosis and therapy · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael J MackBaylor Health Care System, 1100 Allied Drive, Plano, TX 75075, USA. michaema@baylorhealth.edu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The STICH trial showed that CABG surgery does not necessarily improve cardiovascular outcomes in patients with coronary artery disease and left ventricular dysfunction who are receiving optimal medical therapy. However, surgical revascularization should still be considered if the coronary artery disease is severe and viable myocardium can be identified.

Indexed as

Coronary Artery BypassCardiovascular AgentsCoronary Artery DiseaseEvidence-Based MedicineHumansPatient SelectionPractice Guidelines as TopicRandomized Controlled Trials as TopicTreatment OutcomeVentricular Dysfunction, LeftCardiovascular Agents

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.